https://www.selleckchem.com/pr....oducts/abraxane-nab-
Patients with coronavirus disease 2019 (COVID-19) who have underlying malignancy have a higher mortality rate compared with those without cancer, although the magnitude of such excess risk is not clearly defined. We performed a systematic review and pooled analysis to provide precise estimates of the mortality rate among patients with both cancer and COVID-19. A systematic literature search involving peer-reviewed publications, preprintsand conference proceedings up to July 16, 2020, was performed. The primary end-point
Like
Comment
Share
